GB1598080A - Immunoglobulin having a reduced ability to fix complement a process for its preparation and agents containing this immunoglobulin - Google Patents

Immunoglobulin having a reduced ability to fix complement a process for its preparation and agents containing this immunoglobulin Download PDF

Info

Publication number
GB1598080A
GB1598080A GB53480/77A GB5348077A GB1598080A GB 1598080 A GB1598080 A GB 1598080A GB 53480/77 A GB53480/77 A GB 53480/77A GB 5348077 A GB5348077 A GB 5348077A GB 1598080 A GB1598080 A GB 1598080A
Authority
GB
United Kingdom
Prior art keywords
immunoglobulin
phosphate
agent
sulfitolytic
protein
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB53480/77A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Siemens Healthcare Diagnostics GmbH Germany
Original Assignee
Behringwerke AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Behringwerke AG filed Critical Behringwerke AG
Publication of GB1598080A publication Critical patent/GB1598080A/en
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/06—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies from serum
    • C07K16/065—Purification, fragmentation
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/827—Proteins from mammals or birds
    • Y10S530/829—Blood
    • Y10S530/83—Plasma; serum
    • Y10S530/831—Cohn fractions

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
GB53480/77A 1976-12-23 1977-12-22 Immunoglobulin having a reduced ability to fix complement a process for its preparation and agents containing this immunoglobulin Expired GB1598080A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2658334A DE2658334C3 (de) 1976-12-23 1976-12-23 Verfahren zum Herstellen von Immunglobulinpräparationen mit verminderter Komplementaktivität und ein diese enthaltendes Arzneimittel

Publications (1)

Publication Number Publication Date
GB1598080A true GB1598080A (en) 1981-09-16

Family

ID=5996330

Family Applications (1)

Application Number Title Priority Date Filing Date
GB53480/77A Expired GB1598080A (en) 1976-12-23 1977-12-22 Immunoglobulin having a reduced ability to fix complement a process for its preparation and agents containing this immunoglobulin

Country Status (18)

Country Link
US (1) US4160763A (enExample)
JP (1) JPS5379023A (enExample)
AT (1) AT359638B (enExample)
BE (1) BE862290A (enExample)
BR (1) BR7708559A (enExample)
CA (1) CA1105383A (enExample)
CH (1) CH639394A5 (enExample)
DE (1) DE2658334C3 (enExample)
DK (1) DK151610C (enExample)
ES (1) ES465180A1 (enExample)
FR (1) FR2375247A1 (enExample)
GB (1) GB1598080A (enExample)
IL (1) IL53670A (enExample)
IN (1) IN146967B (enExample)
MX (1) MX4329E (enExample)
NL (1) NL190473C (enExample)
PT (1) PT67436B (enExample)
SE (1) SE7714647L (enExample)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4296027A (en) * 1977-08-31 1981-10-20 The Regents Of The University Of Minnesota Pure intravenous human and animal gamma globulins
AT359641B (de) * 1978-09-19 1980-11-25 Immuno Ag Verfahren zur herstellung eines intravenoes ver- abreichbaren antikoerperhaeltigen immunglobulin- praeparates
DE2853453A1 (de) * 1978-12-11 1980-06-19 Behringwerke Ag Mittel zur therapie von immunkomplexerkrankungen
CA1153695A (en) * 1979-08-30 1983-09-13 Syoji Ono S-sulfonated immunoglobulin composition having a high monomer content and a process for production thereof
US4374763A (en) * 1979-09-17 1983-02-22 Morishita Pharmaceutical Co., Ltd. Method for producing gamma-globulin for use in intravenous administration and method for producing a pharmaceutical preparation thereof
US4442032A (en) * 1980-12-04 1984-04-10 Lilly Industries Limited Isothiocyanato-azobenzene-sulfonic, arsonic and substituted-glutamic acid haptens
US4479895A (en) * 1982-05-05 1984-10-30 E. I. Du Pont De Nemours And Company Immunoglobulin half-molecules and process for producing hybrid antibodies
US4470925A (en) * 1982-05-05 1984-09-11 E. I. Du Pont De Nemours And Company Immunoglobulin half-molecules and process for producing hybrid antibodies
US10246485B2 (en) 2013-11-08 2019-04-02 Csl Limited Method to concentrate von willebrand factor or complexes thereof

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2234069A1 (de) * 1971-07-16 1973-02-08 South African Inventions Verfahren zur herstellung eines gereinigten gamma-globulins
DE2404265C3 (de) * 1974-01-30 1980-05-29 Behringwerke Ag, 3550 Marburg Verfahren zum Abreichen von Immunglobulinen
DE2560155C2 (de) * 1974-03-08 1984-04-26 Teijin Ltd., Osaka Humanimmunglobulin-Derivat
DE2527064C3 (de) * 1975-06-18 1979-11-15 Biotest-Serum-Institut Gmbh, 6000 Frankfurt Verfahren zur Herstellung eines intravenösen Nativ-Human-Immunglobulin-Präparates mit natürlicher Halbwertszeit und gegenüber dem Ausgangsmaterial unveränderten Antikörperaktivität
FR2322611A2 (fr) * 1975-09-06 1977-04-01 Biotest Serum Institut Gmbh Procede de preparation de gamma-globuline
US4075193A (en) * 1976-11-26 1978-02-21 Parke, Davis & Company Process for producing intravenous immune globulin

Also Published As

Publication number Publication date
FR2375247B1 (enExample) 1980-11-28
NL190473C (nl) 1994-03-16
ATA922777A (de) 1980-04-15
IN146967B (enExample) 1979-10-20
SE7714647L (sv) 1978-06-24
FR2375247A1 (fr) 1978-07-21
PT67436A (de) 1978-01-01
CA1105383A (en) 1981-07-21
JPS5379023A (en) 1978-07-13
MX4329E (es) 1982-03-25
AT359638B (de) 1980-11-25
DE2658334A1 (de) 1978-06-29
PT67436B (de) 1979-09-20
BE862290A (fr) 1978-06-23
DE2658334B2 (de) 1980-06-04
CH639394A5 (de) 1983-11-15
NL7713980A (nl) 1978-06-27
DK151610B (da) 1987-12-21
NL190473B (nl) 1993-10-18
DE2658334C3 (de) 1987-05-07
BR7708559A (pt) 1978-08-15
ES465180A1 (es) 1979-01-01
DK574577A (da) 1978-06-24
US4160763A (en) 1979-07-10
DK151610C (da) 1988-06-20
IL53670A (en) 1980-10-26

Similar Documents

Publication Publication Date Title
Lin et al. Characteristics of the isolated purine nucleotide binding protein from brown fat mitochondria
Ostrow et al. The protein-binding of C 14-bilirubin in human and murine serum
US4093606A (en) Method of producing intravenously injectable gamma globulin and a gamma globulin suitable for carrying out the method
Tanford et al. Recovery of native conformation of rabbit immunoglobulin G upon recombination of separately renatured heavy and light chains at near-neutral pH
US4670544A (en) Process for the manufacture of the cold insoluble globulin and pharmaceutical preparation containing it
GB1597204A (en) Process of preparing a serum protein composition for intravenous application
EP0967995A1 (en) Composition comprising immunoglobulin
GB1598080A (en) Immunoglobulin having a reduced ability to fix complement a process for its preparation and agents containing this immunoglobulin
US4191533A (en) Pregnancy-specific β1 -glycoprotein and process for isolating it
US4404131A (en) Method of producing a factor-VIII(AHF)-high-concentrate
FI61192B (fi) Foerfarande foer framstaellning av ett saosom diagnostiskt medel anvaendbart vaevnadsprotein
Malpress et al. Studies on human αs-and κ-casein fractions and human caseinoglycomacropeptide
Tanford et al. Gross conformation of free polypeptide chains from rabbit immunoglobulin G. II. Light chain
Kato et al. Ca2+-sensitivity of actomyosin ATPase purified from Physarum polycephalum
EP0025321B1 (en) Composition containing s-sulfonated immunoglobulin and aggregation preventing or aggregate dissociating agent therefor, and processes for preparing compositions containing high proportions of monomeric s-sulfonated immunoglobulin
Waldesbuhl et al. Anticomplementary activity of γG-immunoglobulins and of their subunits
Reynolds et al. Structural units of canine serum and secretory immunoglobulin A
Deutsch Relationships of two light chain immunoglobulins isolated from the same human source (low molecular weight immunoglobins)
Kinkade Jr et al. Isolation and characterization of murine lactoferrin
US4065445A (en) Pregnancy-specific β1 -glycoprotein and process for isolating it
Siess et al. A simple method for the preparation of pure and active gamma-globulin-ferritin conjugates using glutaraldehyde
Lebreton et al. Immunochemical and biochemical study of a human Fcμ fragment (μ‐chain disease)
Bata et al. The effect of urea of antibody-antigen reactions
Hunneyball et al. Subfragmentation of the Fc fragment of human IgG1 myeloma protein by thermolysin
GB1599435A (en) Glycoprotein and process for its production

Legal Events

Date Code Title Description
PS Patent sealed [section 19, patents act 1949]
PE20 Patent expired after termination of 20 years

Effective date: 19971221